Avalo Therapeutics, Inc. (AVTX)
$13.24-3.00%Close
SELLCRISIS · day 23
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $150M
- Beta
- 0.79
- P/E (TTM)
- -2.87
- Short % float
- 105.23%
- Days to cover
- 8.8
- SI change
- -11.8%
- 1W
- -9.32%
- 1M
- -17.87%
- vs SPY 1W
- -9.74%
- vs SPY 1M
- -19.93%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on AVTX?
- LOPJLB’s latest quantitative signal on Avalo Therapeutics, Inc. (AVTX) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is AVTX in?
- Avalo Therapeutics, Inc. (AVTX) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Avalo Therapeutics, Inc. (AVTX) do?
- Avalo Therapeutics, Inc. is a precision medicine company in the clinical development phase, dedicated to identifying, advancing, and marketing specialized treatments for patients experiencing critical unmet medical needs across the fields of immunology, immuno-oncology, and rare genetic disorders. Among its key pipeline assets is AVTX-002, a fully human monoclonal antibody designed to inhibit L…